|
Volumn 27, Issue 5, 1998, Pages 1383-1387
|
Efficacy of Thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
IMMUNOMODULATING AGENT;
THYMOSIN ALPHA1;
VIRUS DNA;
DRUG DERIVATIVE;
THYMOSIN;
ADOLESCENT;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
HUMAN TISSUE;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
SURVIVAL;
ADOLESCENT;
ADULT;
AGED;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
MALE;
MIDDLE AGED;
SURVIVAL ANALYSIS;
THYMOSIN;
|
EID: 0031596591
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510270527 Document Type: Article |
Times cited : (134)
|
References (8)
|